Magenta Medical
Updated: August 03, 2025
CEO David Israeli
Country: Israel | Funding: $179M (+)
Website: http://www.magentamed.com/
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
Website: http://www.magentamed.com/
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
